Skip to main content
Press Release

Catskill Doctor Arrested for Unlawful Drug Distribution

For Immediate Release
U.S. Attorney's Office, Northern District of New York

ALBANY, NEW YORK – Myra Mabry, age 48, a doctor of osteopathic medicine residing in Catskill, New York, was arrested today and charged with distributing controlled substances outside the course of professional practice and for no legitimate medical purpose.

The announcement was made by United States Attorney Grant C. Jaquith; James J. Hunt, Special Agent in Charge, U.S. Drug Enforcement Administration (DEA), New York Field Division; and Joshua Vinciguerra, Director of the New York State Department of Health, Bureau of Narcotic Enforcement.

According to a criminal complaint, Mabry authorized approximately 51 prescriptions for the controlled substance oxycodone, between May 2015 and January 2017, that a co-conspirator filled and picked up at pharmacies in Greene County.  Additionally, between November 2015 and June 2017, Mabry authorized approximately 44 prescriptions for the controlled substances oxycodone and hydromorphone, which were issued to another person but which Mabry filled and picked up at a Greene County pharmacy.

The charges in the complaint are merely accusations. The defendant is presumed innocent unless and until proven guilty.

Mabry appeared today in Albany before United States Magistrate Judge Daniel J. Stewart, who ordered her detained pending a detention hearing on Monday, March 12.

If convicted, Mabry faces up to 20 years in prison, at least 3 years of post-imprisonment supervised release, and a maximum $1 million fine.  A defendant’s sentence is imposed by a judge based on the particular statute the defendant is charged with violating, the U.S. Sentencing Guidelines and other factors.

This case is being investigated by the DEA and the New York State Department of Health, Bureau of Narcotic Enforcement, with assistance from the Catskill Police Department, and is being prosecuted by Assistant U.S. Attorney Wayne A. Myers.

Updated March 9, 2018

Drug Trafficking
Prescription Drugs